The Regenerative Medicine: Taking the Science to the Patient course will run from 30 November – 1 December 2017 in Vienna, Austria
THURSDAY 30 NOVEMBER
08:45 | Welcome | M Comer & M Fritz, Vienna & R Schmid, Berne |
09:00 | Keynote 1: Infarct healing as a therapeutic target |
|
Chairman: R Schmid, Berne |
||
Infarct healing as a therapeutic target | KC Wollert, Hannover | |
09:30 | Session 1: Secretome and regeneration-New kid on the block | |
Chairmen: J Kluin, Amsterdam & E Tschachler, Vienna |
||
Presentations: | ||
Secretome and regeneration: From initial to current work | M Gnecchi, Pavia | |
Secretome-based regeneration from skin to heart | HJ Ankersmit, Vienna | |
Secretome and MOA | M Mildner, Vienna | |
11:00 | Break | |
11:30 | Session 2: ATMPs versus biologicals | |
Chairmen: M Chabicovsky, Vienna & D Niese, Freiburg |
||
Presentations: | ||
Safety testing of biologics and advanced therapies | M Chabicovsky, Vienna | |
Potency assay development of drug compounds in regenerative medicine | M Erb, Germany | |
Regulatory affairs – from science to translation | T Ostler, Germany | |
Bringing a cellular therapy to the market: A skin to patient story | D Niese, Freiburg | |
13:00 | Lunch | |
14:00 | Session 3: Regulatory affairs, GMP production and clinical trials | |
Chairmen: B Reinprecht & I Reischl, Vienna |
||
Presentations: | ||
Regulatory affairs – update | I Reischl, Vienna | |
GMP production: Regulatory prerequisites | A Peterbauer-Scherb, Linz | |
Delivering the product to the patient in a clinical trial centre | U Jäger, Vienna | |
New regulation for ancillary/Raw materials for cell therapy | K Schallmoser, Salzburg | |
15:30 | Session 4: Adipose – derived mesenchymal stem cells in ischemic heart disease | |
Chairmen: T Marti, Berne & J Wojta,Vienna | ||
Presentations: | ||
Cell- or paracrine-mediated reparative effects in the infarct heart | G Vilahur, Barcelona | |
Young Investigator Nominee | ||
Young Investigator Nominee | ||
16:30 | Break and Posters | |
17:30 | Session 5: Humans trials with ATMP secretome – from trachea, skin and valve tissue | |
Chairmen: M Gyongyosi & K Hoetzenecker, Vienna | ||
Presentations: | ||
Nerval regeneration in reconstructive therapy | C Radtke, Vienna | |
Tracheal transplantation -current state and future aspects | K Hoetzenecker, Vienna | |
Heart-stem cell transplantation: Reality check and future | M Gyongyosi, Vienna | |
Valve tissue – from bench to bedside | J Kluin, Amsterdam | |
19:00 | Close |
FRIDAY 1 DECEMBER
08:30 | Keynote 2: Cellular plasticity and tissue regeneration | |
Chairmen: M Comer, Vienna & R Schmid, Berne |
||
Keynote Presentation: | ||
Molecular and cellular dynamics of muscle regeneration in health and disease | L Puri, San Diego | |
Cellular plasticity and tissue regeneration: What can we learn from tumour biology | T Marti, Berne | |
Optimisation of a human lung organoid model for lung regeneration | S Hall, Berne | |
10:30 | Break | |
11:00 | Session 6: Inflammation and immunology | |
Chairmen: MB Fischer & H Stockinger, Vienna |
||
Presentations: | ||
Humoral immunity in the inflamed heart | C Binder, Vienna | |
Inflammation and heart – myocarditis and AMI | U Eriksson, Zurich | |
Young Investigator Nominee | ||
Young Investigator Nominee | ||
12:30 | Lunch | |
13:30 | Session 7: Micro RNAs as important regulators | |
Chairmen: J Grillari & H Redl, Vienna |
||
Presentations: | ||
Therapeutic of MSC Evs | B Giebel, Essen | |
Correlation bone structure and miRNA plasma levels | R Kocijan, Vienna | |
miRNA levels in a model of osteoporosis and therapy | M Hackl, Vienna | |
Endothelial extracellular vesicles-promises and challenges | W Holnthoner, Vienna | |
14:30 | Session 8: Cell and gene therapy | |
Chairmen: D Strunk, Salzburg & T Winkler, Berlin | ||
Presentations: | ||
Placental stromal cells for regeneration of injured gluteal muscle after hip arthroplasty | T Winkler, Berlin | |
Back to the future-new strategies in gene therapy | C von Kalle, Heidelberg | |
What if we could give the body instructions to produce its own drugs? | A Schneeberger, Vienna | |
Why we develop iPSC therapy strategies | D Strunk, Salzburg | |
16:30 | Break | |
17:00 | Session 9: Mechano-biological aspects of cell behaviour | |
Chairmen: S Hall & H Redl, Vienna |
||
Presentations: | ||
Hippo effector protein YAP as the master regulator of cell-matrix interaction in health and disease | G Forte, Brno | |
Mechanical stimulation by shockwave therapy induces myocardial regeneration | J Holfeld, Innsbruck | |
The importance of mechanotransduction in myogenesis | P Heher, Vienna | |
Effects of shockwave on adipose derived stem cells | J Maier, Linz | |
Calcification of the heart valve by TLR3 | J Holfeld, Innsbruck | |
18:30 | Close |
COURSE INFORMATION
Date/Duration
30 November – 1 December 2017 (2 day course)
Location
Courtyard by Marriott Prater/Messe, Trabrennstraße 4, 1020 Vienna
Click HERE for more information.
Course Directors
HJ Ankersmit, Vienna; M Comer, Vienna; T Marti, Berne; R Schmid, Berne
Course Format
Symposium
Course Fee
Industry: €250 inclusive of VAT
University representatives & Members: €150 inclusive of VAT
Students: €30 inclusive of VAT
Fee includes lunch and refreshments on 30 November and 1st December.
Target Audience
Cardio-thoracic surgeons interested in basic science, regulatory affairs involved in applied research, and the translation of ATMP- and secretome based regenerative medicine. Basic Scientists, Biologists, Biotechnologists, Residents and Fellows of all surgical specialities are most welcome.
Learning objectives
Regenerative Medicine has become the mantra of multiple innovation driven academic institutions and the nidus of multiple commercial enterprises. Academia is working on the modification and broadening of scientific insights in relation to advanced therapy medical products (ATMPs) – the technical term for “stem cell therapy” and small molecule therapy. In addition participants will learn about “paracrine factors” and their regenerative ability from in vitro to preclinical research applications. A further objective of this symposium is the description of the complex interplay between regulatory affairs and basic science in order to transfer scientific research to the patients in need.
ABSTRACTS
Click here to view the call for abstracts.

Faculty
-
Hendrik Jan Ankersmit
-
Christoph Binder
-
Monika Chabicovsky
-
Michael Comer
-
Michael Erb
-
Giancarlo Forte
-
Sean Hall
-
Johannes Holfeld
-
Bernd Giebel
-
Massimiliano Gnecchi
-
Jolanda Kluin
-
Thomas Marti
-
Detlef Niese
-
Tobias Ostler
-
Mariann Pavone-Gyöngyösi
-
Anja Peterbauer-Scherb
-
Pier Lorenzo Puri
-
Heinz Redl
-
Ilona Reischl
-
Katharina Schallmoser
-
Achim Schneeberger
-
Ralph Schmid
-
Hannes Stockinger
-
Dirk Strunk
-
Gemma Vilahur
-
Christof von Kalle
-
Tobias Winkler
-
Johann Wojta
-
Kai Wollert